Live Breaking News & Updates on Atinas Biopharma Holdings Kurs

Stay updated with breaking news from Atinas biopharma holdings kurs. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Matinas BioPharma Announces Positive in vivo Safety Data with its Oral LNC-Docetaxel Formulation

25.03.2024 - Daily oral LNC-docetaxel, at a total administered dose of more than 8x greater than IV-docetaxel, showed no evidence of weight loss, compared to an average peak weight loss of 20% with IV-docetaxel Results build on data from prior in vivo study of . Seite 1 ....

United States , Jamesj Ferguson , Matinas Biopharma Holdings Inc , Business Update Conference Call , Biopharma Holdings , Chief Medical Officer , Matinas Biopharma Holdings Chart , Atinas Biopharma Holdings Kurs , Atinas Biopharma Holdings Aktie ,

Matinas BioPharma Successfully Reaches Agreement with FDA for a Single Phase 3 Registration Trial to Support an NDA for MAT2203 for the Treatment of Invasive Aspergillosis

20.02.2024 - ORALTO Phase 3 trial focused on desired initial target indication of early oral step-down treatment of invasive aspergillosis infections in adults who have limited or no treatment options Non-inferiority trial will enroll approximately 216 patients . Seite 1 ....

United States , Jeromed Jabbour , Theresa Matkovits , Compassionate Expanded Use Access Program , Drug Administration , Expanded Use Access Program , Chief Development Officer , Chief Executive Officer , Matinas Biopharma Holdings Chart , Atinas Biopharma Holdings Kurs , Atinas Biopharma Holdings Aktie ,